$20.20

+0.22 (+1.10%)

Weekly Expected Move ±4.9%

$18 $19 $20 $21 $22

NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 46 · $5.5B mcap · 273M float · 0.134% daily turnover · Short 15% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$1.1B +3.2% ▲

5Y CAGR: +11.5%

Gross Profit

$330M +9.3% ▲

5Y CAGR: +11.2%

Operating Income

$183M +13.6% ▲

5Y CAGR: +12.2%

Net Income

$134M +14.0% ▲

5Y CAGR: +11.3%

EPS (Diluted)

$0.49 +14.0% ▲

5Y CAGR: +11.8%

EBITDA

$268M +8.2% ▲

5Y CAGR: +11.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$844M	$984M	$1.1B	$1.1B	$1.1B
YoY Growth	+27.5%	+16.6%	+10.3%	+1.7%	+3.2%
Cost of Revenue	$579M	$664M	$745M	$802M	$809M
Gross Profit	$265M	$320M	$340M	$302M	$330M
Gross Margin	31.4%	32.5%	31.3%	27.4%	29.0%
R&D Expenses	$30M	$34M	$36M	$32M	$24M
SG&A Expenses	$83M	$112M	$114M	$119M	$123M
Operating Expenses	$103M	$127M	$139M	$141M	$147M
Operating Income	$162M	$192M	$201M	$161M	$183M
Operating Margin	19.2%	19.6%	18.5%	14.6%	16.1%
Interest Expense	$5M	$4M	$4M	$7M	$22M
Income Before Tax	$166M	$188M	$190M	$160M	$182M
Tax Expense	$31M	$45M	$44M	$43M	$47M
Net Income	$134M	$143M	$146M	$118M	$134M
Net Margin	15.9%	14.5%	13.4%	10.7%	11.8%
EPS (Diluted)	$0.53	$0.53	$0.55	$0.43	$0.49
EBITDA	$227M	$256M	$272M	$248M	$268M
Shares Outstanding	265M	265M	265M	273M	273M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$278M	$331M	$257M	$280M	$303M	$343M	$274M	$302M
Cost of Revenue	$203M	$232M	$187M	$201M	$215M	$237M	$198M	$215M
Gross Profit	$74M	$98M	$70M	$79M	$88M	$106M	$75M	$87M
Gross Margin	26.8%	29.7%	27.2%	28.1%	29.2%	30.9%	27.5%	28.7%
R&D Expenses	$7M	$6M	$6M	$6M	$8M	$6M	$6M	$6M
SG&A Expenses	$28M	$31M	$30M	$32M	$31M	$34M	$30M	$32M
Operating Expenses	$33M	$31M	$35M	$37M	$36M	$40M	$36M	$48M
Operating Income	$41M	$67M	$35M	$41M	$53M	$66M	$39M	$39M
Operating Margin	14.8%	20.2%	13.5%	14.8%	17.4%	19.2%	14.2%	12.9%
Interest Expense	$2M	$3M	$1M	$2M	$2M	$5M	$1M	$2M
Income Before Tax	$41M	$65M	$35M	$39M	$49M	$65M	$39M	$38M
Tax Expense	$11M	$16M	$9M	$9M	$13M	$18M	$11M	$15M
Net Income	$30M	$48M	$27M	$30M	$36M	$47M	$28M	$23M
Net Margin	10.8%	14.6%	10.3%	10.6%	11.9%	13.7%	10.2%	7.6%
EPS (Diluted)	$0.11	$0.18	$0.10	$0.11	$0.13	$0.17	$0.10	$0.08
EBITDA	$103M	$87M	$57M	$62M	$73M	$94M	$65M	$40M
Shares Outstanding	273M	273M	273M	273M	273M	273M	273M	273M

STVN NYSE